HOPE IN ACTION

Frizzle Fundraising Campaign to get a clinical trial started by September 2026

2026 the Year for Frizzle Treatment

But only with your support!

  • Our pre-clinical research on Frizzle (FRRS1L) mouse models showed the restoration of brain and motor function through gene replacement therapy. This research leads us to hope and believe Frizzle gene therapy treatment will bring patients back to function!

  • Our goal is to begin treating Frizzle patients by September of this year with gene replacement therapy given as a one-time dose.

  • We have a clear plan, committed partners, and a defined timeline. What remains is raising the funds needed to bring this treatment across the finish line and into patients.

  • We must raise $4 million to cover both the manufacturing of the drug and the costs of treating patients in a clinical trial.

  • Every donation goes directly toward changing lives and changing the world!

THANK YOU!